Inicio

Innovando en Evaluación Económica para generar eficiencia y sostenibilidad.

El valor de la investigación en Salud

Comprometidos con el desarrollo sostenible del sistema sanitario, fijamos bases para el futuro tomando decisiones en el presente.
Para nosotros, la flexibilidad es estratégica.

Publicaciones destacadas

Excess mortality during the COVID-19 pandemic in Spain by non-COVID-19 causes of death

Cost-Per-Responder Analysis of Bimekizumab (IL-17A/F inhibitor) against IL-17A and IL-12/23 Targeted Therapies for Psoriatic Arthritis in Spain, based on Matching-Adjusted Indirect Comparisons (MAIC)

Cost-per-Responder Analysis of Bimekizumab (IL-17A/F Inhibitor) Against IL-23 Targeted Therapies for Psoriatic Arthritis in Spain, Based on Matching-Adjusted Indirect Comparisons (MAIC)